Gnudi, Luigi - professor in diabetes and metabolic medicine


Consultant profiles

Luigi Gnudi, professor in diabetes and metabolic medicine


Tel: 020 7188 1932 / 020 7848 4413

Area of expertise: diabetic nephropathy, diabetic vascular complications


  • Biography

    Professor Luigi Gnudi obtained his MD with Honours from the University of Parma (Italy) in 1988.

    He subsequently joined the residency programme at the School of Diabetes and Endocrinology at the University of Padua (Italy) (1989-1993).

    During 1993-1995, he worked as a postdoctoral-fellow with Professor Barbara B. Kahn at Beth Israel Hospital, Harvard Medical School, Boston.

    In 1998 he obtained a PhD in Endocrinological Sciences from the University of Milan.

    He became a Fellow of both the Royal College of Physicians and the American Society of Nephrology in 2005.

    Dr Gnudi joined the Unit for Metabolic Medicine (within the Department of Diabetes, Endocrinology and Internal Medicine) at King's College London in 1997 as senior lecturer and was promoted to professor of diabetes and metabolic medicine in 2011. He became head of the Unit for Metabolic Medicine in 2010.

    He is the subject editor for Nephrology Dialysis and Transplantation, Metabolism, Diabetologia and the Journal of the American Society of Hypertension. He's also the President of the Italian Medical Society of Great Britain.

    Professor Gnudi is a member of the following organisations:

    • Diabetes UK
    • European Association for the Study of Diabetes
    • American Diabetes Association
    • American Society of Nephrology
    • European Diabetic Nephropathy Study Group
    • Physiological Society
    • ERA-EDTA
    • Faculty 1000.
  • Specialist interests

    • diabetic nephropathy
    • chronic diabetic vascular complications.
  • Research interests

    • vascular complications in diabetes with a specific interest in the kidney
    • as a Member of the NIHR Biomedical Research Centre’s Faculty of Translational Medicine, Luigi is actively involved, as lead investigator, in clinical trials looking for new treatment for diabetic chronic vascular complications.